** CREDENTIALED PRESS ONLY **
A media briefing on new safety controlsfor long-acting beta agonists, medications used to treat asthma
--Janet Woodcock, M.D., director, Center for Drug Evaluation and Research (CDER), FDA
--Gerald Dal Pan, M.D., director, Office of Surveillance and Epidemiology, CDER, FDA
--Badrul Chowdhury, M.D., director, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER, FDA
--Sally Seymour, M.D., deputy director for safety, Division of Pulmonary and Allergy Products, Office of Drug Evaluation II, CDER
Thurs., Feb. 18, 2010, 1:15 p.m. EST
Reporters may participate in a listen-only mode by dialing 888-455-0031 or for international reporters, 1-312-470-0068. The password for all callers is "FDA." A replay of the briefing will be available until Feb. 25 by calling 888-562-2793 or for international reporters, 1-402-998-1450.
CONTACT: Karen Riley, 301-796-4674 (office), email@example.com, or Erica Jefferson, 301-796-4988, firstname.lastname@example.org, both of FDA
/PRNewswire-USNewswire -- Feb. 18/
SOURCE U.S. Food and Drug Administration
Subscribe to our Free Newsletters!
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused ...
Dysthymia or persistent depressive disorder (PDD) is a chronic low mood and self-esteem affecting ...
Vitamin A is an extremely vital vitamin needed for the eyes, skin, hair, immunity and during ...View All